Thermo Fisher Scientific plans to acquire a Philadelphia-based clinical trial software company for $8.9 billion from a ...

Thermo Fisher Scientific plans to acquire a Philadelphia-based clinical trial software company for $8.9 billion.

The decision to build versus buy shouldn't be taken lightly, but it shouldn't be avoided either. Smart organizations follow a ...

By taking into account a more thorough analytical download, history indicates that hot stocks and emerging themes eventually ...

Bryn Talkington, Managing Partner of Requisite Capital Management, explained in a recent program on CNBC why she sold her ...

INTU serves as Oracle's counterpart in the Application Software sector, which possesses: 1) A lower valuation (P/OpInc) in comparison to Oracle stock 2) However, it demonstrates superior revenue and ...

Since bottoming out in late 2022, Palantir Technologies (NASDAQ: PLTR) stock has risen by a remarkable 2,700%. And with a run like that behind it, new investors might naturally wonder if the stock is ...

Palantir stock has a solid track record of surprising on earnings. In three of the past four quarters, PLTR stock has jumped ...

BigBear.ai ( BBAI +3.98%) is among the many artificial intelligence (AI) stocks that have been soaring in 2025. Its shares ...

Check Point Software's promising earnings report should serve as a reminder for investors not to forget about the Steady ...

The stock carries a premium price tag. After posting incredible returns in 2023 and 2024, Palantir (NASDAQ: PLTR) stock has ...

Buying $1,000 in CN Rail or Constellation is a dead-easy investing decision to make as both blue-chip stocks trade at a ...